Work

The Proposed Drug Conditional Approval Pathway and Responses From Cancer Survivors

Year: 2026

Type: article

Abstract: This survey study assesses understanding of and responses to the proposed US Food and Drug Administration conditional drug approval pathway among individuals who have received prior treatment for cancer or are currently undergoing treatment.

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2026.0117

Authors: Luke W. Chen, Sarah Long, Sharon P. Shriver, Mark E. Fleury

Institution: American Cancer Society

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000